冠状动脉血运重建术后围术期心肌梗死替代定义的意义
基于EXCEL试验中左主干冠状动脉疾病患者随机接受PCI或CABG的数据,分析不同围术期心肌梗死(PMI)定义的发生率和临床相关性。预设方案定义PMI(PMIProt)在PCI后3.6%、CABG后6.1%;第三次通用定义PMI(PMIUD)在PCI后4.0%、CABG后2.2%。PMIProt与5年心血管死亡率在两种血运重建后均相关,而PMIUD仅与CABG后死亡率强相关。
要点
- 不同PMI定义导致PCI和CABG后PMI发生率差异显著。
- PMIProt与PCI和CABG后5年心血管死亡率均相关。
- PMIUD仅与CABG后死亡率强相关,与PCI后无关。
核心结论
- PCI和CABG后PMI发生率因定义不同而差异很大。
- 在EXCEL试验中,预设PMIProt与PCI和CABG后相似的风险相关,而PMIUD与CABG后死亡率强相关但与PCI后无关。
研究设计与样本
- EXCEL试验的事后分析,纳入左主干冠状动脉疾病随机接受PCI或CABG的患者。
- PMIProt要求肌酸激酶-MB(CK-MB)大幅升高,两种手术阈值相同。
- PMIUD要求较低生物标志物升高但需心肌缺血支持证据,PCI和CABG后标准不同,优先使用肌钙蛋白(49.5%患者可用),否则用CK-MB。
- 分析每种PMI类型与5年死亡率的多变量关系。
主要发现
- PMIProt发生率:PCI后34/935(3.6%),CABG后56/923(6.1%),差异-2.4%(95%CI:-4.4%至-0.5%;p=0.015)。
- PMIUD发生率:PCI后37(4.0%),CABG后20(2.2%),差异1.8%(95%CI:0.2%至3.4%;p=0.025)。
- PMIProt与5年心血管死亡率相关(调整HR:2.18;95%CI:1.13至4.23),PMIUD亦相关(调整HR:2.87;95%CI:1.44至5.73)。
- PMIProt在PCI和CABG后与心血管死亡率的风险一致(交互p=0.86)。
- PMIUD与CABG后心血管死亡率强相关(调整HR:11.94;95%CI:4.84至29.47),但与PCI后无关(调整HR:1.14;95%CI:0.35至3.67)(交互p=0.004)。
关键数值与推荐
- PMIProt定义:要求CK-MB大幅升高,PCI和CABG阈值相同。
- PMIUD定义:要求较低生物标志物升高伴心肌缺血证据,PCI和CABG标准不同,优先使用肌钙蛋白。
- 仅CK-MB≥10倍正常上限和肌钙蛋白≥70倍正常上限的大幅升高与死亡率相关。
临床怎么用
- 临床解读PCI或CABG后PMI时需注意所用定义,不同定义发生率和预后意义差异大。
- 对于CABG后患者,PMIUD与死亡率强相关,可用于风险分层。
- 对于PCI后患者,PMIUD与死亡率无关,应谨慎解读。
- 仅大幅生物标志物升高(CK-MB≥10倍正常上限或肌钙蛋白≥70倍正常上限)与死亡率相关,或应关注此类阈值。
局限性
- 肌钙蛋白仅在49.5%患者中可用,PMIUD评估可能受限。
- 结果为EXCEL试验事后分析,需谨慎解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Varying definitions of procedural myocardial infarction (PMI) are in widespread use. OBJECTIVES: This study sought to determine the rates and clinical relevance of PMI using different definitions in patients with left main coronary artery disease randomized to percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) surgery in the EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial. METHODS: The pre-specified protocol definition of PMI (PMIProt) required a large elevation of creatine kinase-MB (CK-MB), with identical threshold for both procedures. The Third Universal Definition of MI (types 4a and 5) (PMIUD) required lesser biomarker elevations but with supporting evidence of myocardial ischemia, different after PCI and CABG. For the PMIUD, troponins were used preferentially (available in 49.5% of patients), CK-MB otherwise. The multivariable relationship between each PMI type and 5-year mortality was determined. RESULTS: PMIProt occurred in 34 of 935 (3.6%) patients after PCI and 56 of 923 (6.1%) patients after CABG (difference -2.4%; 95% confidence interval [CI]: -4.4% to -0.5%; p = 0.015). The corresponding rates of PMIUD were 37 (4.0%) and 20 (2.2%), respectively (difference 1.8%; 95% CI: 0.2% to 3.4%; p = 0.025). Both PMIProt and PMIUD were associated with 5-year cardiovascular mortality (adjusted hazard ratio [HR]: 2.18 [95% CI: 1.13 to 4.23] and 2.87 [95% CI: 1.44 to 5.73], respectively). PMIProt was associated with a consistent hazard of cardiovascular mortality after both PCI and CABG (pinteraction = 0.86). Conversely, PMIUD was strongly associated with cardiovascular mortality after CABG (adjusted HR: 11.94; 95% CI: 4.84 to 29.47) but not after PCI (adjusted HR: 1.14; 95% CI: 0.35 to 3.67) (pinteraction = 0.004). Results were similar for all-cause mortality and with varying PMIUD biomarker definitions. Only large biomarker elevations (CK-MB ≥10× upper reference limit and troponin ≥70× upper reference limit) were associated with mortality. CONCLUSIONS: The rates of PMI after PCI and CABG vary greatly with different definitions. In the EXCEL trial, the pre-specified PMIProt was associated with similar hazard after PCI and CABG, whereas PMIUD was strongly associated with mortality after CABG but not after PCI. (EXCEL Clinical Trial [EXCEL]; NCT01205776).
引用
- Gregson J, Stone GW, Ben-Yehuda O, et al. Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization. J Am Coll Cardiol. 2020. PMID: 33004126. doi:10.1016/j.jacc.2020.08.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。